Reposted by Richard Marcotte
Scientist NRC, Prof. Associe, Universite de Montreal et Affiliate member Goodman Cancer Institute McGill University. Functional genomic in cancer and immune cells, Cell engineering, gene editing, CRISPR/Cas. Views are my own